Evidence map›Paper›PMID 40688543›Full record

ArticleFrontiers in nuclear medicine2025

Positron emission tomography imaging biomarker and artificial intelligence for the characterization of solitary pulmonary nodule.

Ashish Kumar Jha, Umeshkumar Baburao Sherkhane, Nilendu C Purandare, Leonard Wee, Andre Dekker, Venkatesh Rangarajan

Abstract read
In one paragraph

Article in Frontiers in nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ashish Kumar JhaDepartment of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Umeshkumar Baburao SherkhaneDepartment of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Nilendu C PurandareDepartment of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Leonard WeeDepartment of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Andre DekkerDepartment of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Venkatesh RangarajanDepartment of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The characterization of solitary pulmonary nodules (SPNs) as malignant or benign remains a diagnostic challenge using conventional imaging parameters. The literature suggests using combined Positron Emission Tomography (PET) and Computed Tomography (CT) to characterise a SPN. Radiomics and machine learning are other promising technologies which can be utilised to characterise the SPN. Purpose: This study explores the potential of PET radiomics signatures and machine learning algorithms to characterise the SPN. Methods: This retrospective study aimed to characterize solitary pulmonary nodules (SPNs) using PET radiomics. A total of 163 patients who underwent PET/CT imaging were included in this study. A total of 1,098 features were extracted from PET images using PyRadiomics. To optimize model performance two strategies i.e., (a) feature selection and (b) feature reduction techniques were employed, including hierarchical clustering, RFE in feature selection, and PCA in feature reduction. To address outcome class imbalance, the dataset was statistically resampled (SMOTE). A random forest models was developed using original training set (RF-Model-O & RF-PCA-Model-O) and balanced training dataset (RF-Model-B & RF-PCA-Model-B) and validated on the test datasets. Additionally, 5-fold cross-validation and bootstrap validation was also performed. The model's performance was assessed using various metrics, such as accuracy, AUC, precision, recall, and F1-score. Results: Of the 163 patients (aged 36-76 years, mean age 58 ± 7), 117 had malignant disease and 46 had granulomatous or benign conditions. In Conclusion: The PET radiomics demonstrated excellent performance in characterizing SPNs as benign or malignant.

Indexed as

bootstrapcross-validationlung cancerpet scanradiomicsrandom forest algorithmSMOTESPN

Identifiers

PMID40688543
PMCPMC12271206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.